Self‐regulation of autologous cell therapies-Reference-Cited by-同舟云学术

Self‐regulation of autologous cell therapies

Published:2014-03 Issue:4 Volume:200 Page:196-196
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Tuch Bernard E¹²,Wall Dominic M³⁴

Affiliation:

1. NSW Stem Cell Network, Sydney, NSW.

2. Centre for Genetic Diseases, Monash Institute of Medical Research, Monash University, Melbourne, VIC.

3. Australia and New Zealand Region, International Society for Cellular Therapy, Melbourne, VIC.

4. Department Pathology, University of Melbourne, Melbourne, VIC.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja13.11043

Reference5 articles.

1. Macquarie Stem Cells.Candidacy.www.macquariestemcells.com/suitable‐stem‐cell‐candidates(accessed Jan 2014).

2. 2010 Nicolas Andry Award: Multipotent Adult Stem Cells from Adipose Tissue for Musculoskeletal Tissue Engineering

3. Platelet rich plasma for chronic tendinopathy [abstract];Harmon K;Br J Sports Med,2013

4. NSW Stem Cell Network.17th NSW Stem Cell Network Workshop: cellular therapies for repair of musculoskeletal injuries.www.stemcellnetwork.org.au/past_events/workshops/17thWorkBookfinal.pdf(accessed Jan 2014).

5. France launches new drug regulatory agency;Lochouarn M;Lancet,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell and gene therapy manufacturing capabilities in Australia and New Zealand;Cytotherapy;2019-12

2. From the margins to mainstream: How providers of autologous ‘stem cell treatments’ legitimise their practice in Australia;Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine;2019-05-13

3. Hope ‘at Home’: Stem Cell Treatments in Australia;Stem Cell Tourism and the Political Economy of Hope;2017

4. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models;Stem Cells in Clinical Applications;2017

5. Challenges to International Stem Cell Clinical Trials in Countries with Diverging Regulations;Stem Cells in Clinical Applications;2017